Skip to main content

Table 1 Univariate analysis of the relationship between mammaglobin expression and all studied clinical and biological variables

From: Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype

Variable n Mammaglobin > 205.78a (%) OR 95% CI P
Histology      
   Ductal + tubular 108 52 (48) 1.00   
   Lobular 20 12 (60) 1.62 0.61–4.30 0.332
Chemotherapy      
   No 15 55 (49) 1.00   
   Yes 128 9 (60) 1.58 0.52–4.77 0.412
Histological grade      
   1+2 60 32 (53) 1.00   
   3 42 17 (40) 0.60 0.27–1.34 0.203
Nuclear grade      
   1+2 52 30 (58) 1.00   
   3 51 19 (37) 0.44 0.19–0.98 0.039
Nodal metastasis      
   No 70 40 (57) 1.00   
   Yes 55 22 (40) 0.50 0.24–1.04 0.058
DNA ploidy      
   >1 68 27 (40) 1.00   
   1 60 37 (62) 2.44 1.17–5.08 0.014
Oestrogen receptor      
   Negative 34 12 (35) 1.00   
   Positive 93 52 (56) 2.33 1.01–5.34 0.040
Progesterone receptor      
   Negative 62 23 (37) 1.00   
   Positive 66 41 (62) 2.78 1.32–5.84 0.005
c-erbB-2      
   Negative 103 53 (51) 1.00   
   Positive 25 11 (44) 0.74 0.31–1.79 0.505
p53      
   Negative 107 56 (52) 1.00   
   Positive 21 8 (38) 0.56 0.21–1.48 0.235
Ki67      
   ≤ 20% 79 46 (58) 1.00   
   >20% 49 18 (37) 0.42 0.20–0.88 0.019
  1. CI, confidence interval; OR, odds ratio. aMedian for the whole group of patients.
\